1.0Market Newsdeskhttps://www.marketnewsdesk.comNewsdeskhttps://www.marketnewsdesk.com/index.php/author/newsdesk/rich600338<blockquote class="wp-embedded-content" data-secret="7Xex0KVux0"><a href="https://www.marketnewsdesk.com/index.php/biocept-provides-business-update/">Biocept Provides Business Update</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.marketnewsdesk.com/index.php/biocept-provides-business-update/embed/#?secret=7Xex0KVux0" width="600" height="338" title="“Biocept Provides Business Update” — Market Newsdesk" data-secret="7Xex0KVux0" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://www.marketnewsdesk.com/wp-includes/js/wp-embed.min.js </script> Announces receipt of more than 150,000 samples for COVID-19 testing and completes relocation to new facility PR Newswire SAN DIEGO, Dec. 14, 2020 /PRNewswire/ — Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically actionable information to improve patient outcomes, announces that it has received more than 150,000 samples for COVID-19 RT-PCR testing to date and has continued to report the vast majority of results to customers within 48 hours of receiving a sample.  The Company also announces the successful relocation to its new corporate headquarters and molecular laboratory facility in San Diego.  “All clinical operations at the new facility are fully functioning, including our newly designed state-of-art CLIA-certified and … Continue reading ""https://mma.prnewswire.com/media/276540/biocept_inc_Logo.jpg